Literature DB >> 4513360

Hemoglobin abnormalities in neoplastic hematological disorders.

I R Walker, M A Ali.   

Abstract

Fetal hemoglobin (F) and hemoglobin A(2) were estimated in 35 patients with malignant hematological disorders. In 9 out of 10 patients with morphological and cytochemical features of acute myeloblastic leukemia the hemoglobin F was greater than 2%. Of the other 25 patients investigated only one patient with polycythemia rubra vera had a hemoglobin F level of more than 2%. Estimation of fetal hemoglobin may be of value in the classification of acute leukemias and the increased level observed probably reflects disturbed hemoglobin synthesis in the acute myeloblastic type.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4513360      PMCID: PMC1941328     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

2.  Myelomonocytic leukemias: a historical review and perspectives.

Authors:  J M Bennett
Journal:  Cancer       Date:  1971-05       Impact factor: 6.860

3.  Hemoglobin H as an acquired defect of alpha-chain synthesis. Report of two cases.

Authors:  A I Rosenzweig; J D Heywood; A G Motulsky; C A Finch
Journal:  Acta Haematol       Date:  1968       Impact factor: 2.195

4.  Estimation of foetal haemoglobin in leukaemia.

Authors:  G Bartolozzi; L Marianelli
Journal:  Acta Haematol       Date:  1966-04       Impact factor: 2.195

5.  Acquired hemoglobin H disease.

Authors:  R W Hamilton; E Schwartz; J Atwater; A J Erslev
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

6.  Acquired macrocytic anemia and hemoglobinopathy--a paraneoplastic manifestation?

Authors:  M Nyman; R Skölling; H Steiner
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

7.  Fetal hemoglobin in various forms of childhood leukemia. Relation to relapse and remission.

Authors:  S Ozsoylu; S Balci
Journal:  Clin Pediatr (Phila)       Date:  1970-03       Impact factor: 1.168

8.  Raised foetal haemoglobin in childhood leukaemia.

Authors:  D R Miller
Journal:  Br J Haematol       Date:  1969-07       Impact factor: 6.998

9.  Globin synthesis in sideroblastic anaemia. I. Alpha and beta peptide chain synthesis.

Authors:  J M White; M C Brain; M A Ali
Journal:  Br J Haematol       Date:  1971-03       Impact factor: 6.998

10.  Decrease in the concentration of haemoglobin A2 during erythroleukaemia.

Authors:  M Aksoy; S Erdem
Journal:  Nature       Date:  1967-02-04       Impact factor: 49.962

View more
  4 in total

1.  Hemoglobinopathies in the Hamilton region. II. Thalassemia traits and iron therapy.

Authors:  M A Ali
Journal:  Can Med Assoc J       Date:  1975-03-22       Impact factor: 8.262

2.  Detection of acquired hemoglobinopathy in children with hematological malignancies at disease onset: results form a national referral centre.

Authors:  Despoina N Maritsi; Helen V Kosmidis; Varvara Douna; Joanne Traeger-Synodinos; Maria N Tsolia; Lydia Kossiva
Journal:  Int J Hematol       Date:  2013-10-05       Impact factor: 2.490

3.  Hemoglobinopathies in the Hamilton region. I. A 4-year survey.

Authors:  M A Ali
Journal:  Can Med Assoc J       Date:  1975-03-22       Impact factor: 8.262

4.  Ultrasensitive electrochemical molecularly imprinted sensor based on AuE/Ag-MOF@MC for determination of hemoglobin using response surface methodology.

Authors:  Sudabe Mandani; Behzad Rezaei; Ali Asghar Ensafi; Parisa Rezaei
Journal:  Anal Bioanal Chem       Date:  2021-07-08       Impact factor: 4.142

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.